tyrosine has been researched along with Primary Peritonitis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 8 (47.06) | 29.6817 |
2010's | 4 (23.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YH; Hsiao, CC; Hsu, LS; Lee, CH; Lo, HC | 1 |
Aloisi, C; Buemi, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Mazzon, E; Mondello, P; Mondello, S | 1 |
Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I | 1 |
Kamenos, G; Pendem, S; Wilson, JX; Wu, F; Zhou, G | 1 |
Hsiao, CC; Lee, CH; Lo, HC; Tsao, LY | 1 |
Barbera, A; Caputi, AP; Centorrino, T; Chatterjee, PK; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C | 1 |
Bird, MI; Bovin, NV; Nifantiev, NE; Pochechueva, TV; Preobrazhenskaya, ME; Rieben, R; Sablina, MA; Tsvetkov, YE; Tuzikov, AB; Ushakova, NA | 1 |
Autore, G; Britti, D; Cuzzocrea, S; Di Paola, R; Genovese, T; Marzocco, S; Pinto, A; Scollo, G; Sorrentino, R | 1 |
Gill, DS; Lipscomb, AP | 1 |
Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; LaurĂ , R; Mazzon, E | 1 |
Balligand, JL; Combet, S; Devuyst, O; Goffin, E; Lameire, N; Moulin, P; Piech, A; Van Landschoot, M; Verbavatz, JM | 1 |
Caputi, AP; Costantino, G; Cuzzocrea, S; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Mazzon, E; Rossi, F; Scafuro, MA | 1 |
Kodama, S; Mikawa, K; Nishina, K; Obara, H | 1 |
Barbera, A; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fonti, MT; Mazzon, E | 1 |
Belaaouaj, A; Byun, J; Carroll, JA; Gaut, JP; Heinecke, JW; Hotchkiss, RS; Lauber, WM; Tran, HD | 1 |
Kraus, AP; Kraus, LM | 1 |
Demetriou, AA; Levenson, SM; Simon, R; Wetzel, W; Winsey, K | 1 |
17 other study(ies) available for tyrosine and Primary Peritonitis
Article | Year |
---|---|
Diverse effects of parenteral arginine on systemic and local oxidant-antioxidant homeostasis and nitrosative stress in rats with subacute peritonitis.
Topics: Animals; Antioxidants; Arginine; Disease Models, Animal; Energy Intake; Homeostasis; Infusions, Parenteral; Kidney; Lipid Peroxidation; Male; Nitric Oxide; Oxidants; Oxidative Stress; Peritonitis; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Severity of Illness Index; Tyrosine | 2014 |
Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model.
Topics: Animals; Anti-Infective Agents; Blotting, Western; Chlorhexidine; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; I-kappa B Proteins; Immunohistochemistry; Immunosuppressive Agents; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Peroxidase; Poly Adenosine Diphosphate Ribose; Rats; Thalidomide; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A | 2009 |
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan | 2010 |
Ascorbate protects against vascular leakage in cecal ligation and puncture-induced septic peritonitis.
Topics: Animals; Antioxidants; Ascorbic Acid; Capillary Permeability; Cecum; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Muscle, Skeletal; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Occludin; Peritonitis; Protein Phosphatase 2; Sepsis; Superoxides; Tyrosine | 2012 |
The dose-dependent immunoregulatory effects of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester in rats with sub-acute peritonitis.
Topics: Acute Disease; Animals; Arginine; Body Weight; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Humans; Immunomodulation; Infusions, Parenteral; Leukocyte Count; Leukocytes; Male; Nitrates; Nitric Oxide Synthase; Nitrites; Organ Size; Parenteral Nutrition; Peritonitis; Rats; Rats, Wistar; Spleen; Tyrosine | 2012 |
Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
Topics: Animals; Calpain; Cell Movement; Cyclooxygenase 2; Dose-Response Relationship, Drug; Glycoproteins; Immunohistochemistry; Intestinal Mucosa; Intestines; Isoenzymes; Liver; Lung; Male; Malondialdehyde; Multiple Organ Failure; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2002 |
P-selectin blocking potency of multimeric tyrosine sulfates in vitro and in vivo.
Topics: Acrylic Resins; Animals; Chemotaxis, Leukocyte; Dimerization; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Lewis X Antigen; Neutrophils; P-Selectin; Peritonitis; Protein Binding; Rats; Rats, Wistar; Structure-Activity Relationship; Tyrosine | 2003 |
Methylguanidine reduces the development of non septic shock induced by zymosan in mice.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Exudates and Transudates; Immunohistochemistry; Intestinal Mucosa; Intestines; Kidney; Lipid Peroxidation; Lung; Male; Methylguanidine; Mice; Neutrophils; Pancreas; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Shock; Tyrosine; Zymosan | 2004 |
Primary pneumococcal peritonitis associated with tyrosinaemia type 1.
Topics: Amino Acid Metabolism, Inborn Errors; Female; Humans; Infant; Peritonitis; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Tyrosine | 1999 |
Role of interleukin-6 in a non-septic shock model induced by zymosan.
Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan | 1999 |
Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis.
Topics: Acute Disease; Analysis of Variance; Animals; Aquaporin 1; Aquaporins; Capillary Permeability; Disease Models, Animal; Endothelial Growth Factors; Immunoassay; Immunohistochemistry; Isoenzymes; Lymphokines; Male; Nitric Oxide Synthase; Peritoneal Dialysis; Peritoneum; Peritonitis; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
Topics: Animals; Hyperbaric Oxygenation; Lipid Peroxidation; Male; Malondialdehyde; Multiple Organ Failure; Peritonitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2000 |
Propofol attenuates diaphragmatic dysfunction induced by septic peritonitis in hamsters.
Topics: Animals; Cricetinae; Diaphragm; Dose-Response Relationship, Drug; Endotoxins; Immunohistochemistry; In Vitro Techniques; Male; Mesocricetus; Muscle Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritonitis; Propofol; Sepsis; Tyrosine | 2001 |
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peritonitis; Peroxidase; Poly(ADP-ribose) Polymerases; Rhodamines; Shock; Tyrosine; Zymosan | 2001 |
Myeloperoxidase produces nitrating oxidants in vivo.
Topics: Animals; Klebsiella Infections; Klebsiella pneumoniae; Mice; Peritonitis; Peroxidase; Reactive Nitrogen Species; Tyrosine | 2002 |
Tyrosine and N-carbamoyl-tyrosine in end-stage renal disease during continuous ambulatory peritoneal dialysis.
Topics: Adult; Blood Urea Nitrogen; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Time Factors; Tyrosine; Urea | 1991 |
Supplemental dietary tyrosine in sepsis and acute hemorrhagic shock.
Topics: Acute Disease; Animals; Catecholamines; Infections; Male; Peritonitis; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Tyrosine | 1987 |